XML 31 R8.htm IDEA: XBRL DOCUMENT v3.25.1
CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 12 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Dec. 31, 2022
Cash flows from operating activities:      
Net income $ 36,141 $ 28,593 $ 43,022
Adjustments to reconcile net income to net cash provided by operating activities:      
Depreciation and amortization 8,990 10,874 10,037
Accretion of fair value purchase accounting adjustments, net     (2,158)
Amortization of intangible assets 2,425 2,624 2,607
Provision for credit losses     4,018
Provision for credit losses 5,153 3,029  
Stock compensation expense 1,629 1,349 1,300
Gain (loss) on sale of securities available-for-sale (64) 6,801 (144)
Deferred income tax expense (benefit) 120 1,309 (555)
Increase in cash surrender value of bank owned life insurance (2,483) (1,964) (1,851)
Net losses from sale and write-downs of other real estate owned and other repossessed assets 994 78 82
Net gains from mortgage banking (1,463) (1,040) (1,552)
Origination of loans held for sale (49,845) (45,891) (49,258)
Proceeds from sales of loans held for sale 49,730 44,265 54,161
Net (gain) loss from sale/disposal of fixed assets (1,647) 19 (244)
Net change in:      
Accrued interest receivable (898) (2,989) (4,242)
Accrued interest payable 250 2,520 (24)
Other assets 3,788 (1,732) (25,424)
Other liabilities (120) (8,129) 27,018
Net cash provided by operating activities 52,700 39,716 56,793
Cash flows from investing activities:      
Proceeds from sales   152,775 37,390
Proceeds from maturities, calls and paydowns 57,985 56,273 39,614
Purchases (131,376) (130,584) (297,334)
Proceeds from maturities, calls and paydowns 152,486 2,494 1,937
Purchases     (50,575)
Proceeds from sales of other investments 5,960 2,812 1,054
Purchases of other investments (7,407) (944) (91)
Purchases of bank owned life insurance (30,000)    
Net increase in loans and leases (469,247) (213,591) (558,387)
Proceeds from sale of fixed assets 4,698 682 1,460
Proceeds received from dissolved derivative instrument     940
Purchases of premises and equipment (6,405) (6,270) (12,487)
Proceeds from sale of other real estate owned and other repossessed assets 3,084 1,113 542
Net cash (paid) received from business combinations     (4,881)
Net cash used in investing activities (420,222) (135,240) (840,818)
Cash flows from financing activities:      
Net increase in deposits 418,696 190,887 55,630
Net (decrease) increase in securities sold under agreements to repurchase (944) 303 (310)
Proceeds from borrowings 160,100 26,275 30,885
Repayment of borrowings (166,600) (30,775) (76,300)
Cash dividends paid (5,422) (5,427) (4,724)
Issuance of preferred stock of subsidiary - non-controlling interest, net of fees 113    
Issuance of common stock 68 165 397
Restricted shares withheld for taxes (223) (57) (206)
Repurchases of common stock (2,967)    
Net cash provided by financing activities 402,821 181,371 5,372
Net change in cash and cash equivalents 35,299 85,847 (778,653)
Cash and cash equivalents, beginning of period 352,271 266,424 1,045,077
Cash and cash equivalents, end of period 387,570 352,271 266,424
Supplemental disclosures of cash flow information:      
Cash paid during the period for interest 113,665 85,443 21,356
Net cash paid during the period for income taxes 8,774 9,347 12,205
Noncash investing and financing activities:      
Recognition of operating lease assets in exchange for lease liabilities 3,573 1,751 53
Acquisition of real estate through foreclosure 179 $ 272 281
Acquisition of other repossessed assets 4,396    
Financed sales of other repossessed assets $ 1,132    
Transfer of securities from available-for-sale to held-to-maturity     162,378
Change in goodwill due to acquisition     $ 4,580